ng-nitroarginine methyl ester has been researched along with Hepatorenal Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kozłowski, W; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Wesołowski, P | 1 |
| Chen, HX; Chen, X; Deng, LH; Diao, TJ; Gao, BC; Liang, Y; Wang, QH; Ye, Y; Yuan, WS; Zhao, XD | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Hepatorenal Syndrome
| Article | Year |
|---|---|
[Role of nitric oxide system in pathogenesis of experimental model of hepatorenal syndrome].
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Galactosamine; Hepatorenal Syndrome; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 2008 |
Protective effect of nitric oxide on hepatopulmonary syndrome from ischemia-reperfusion injury.
Topics: Alanine Transaminase; Animals; Arginine; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Hepatorenal Syndrome; Immunohistochemistry; Intercellular Adhesion Molecule-1; Liver; Liver Transplantation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Reperfusion Injury; Time Factors; Tumor Necrosis Factor-alpha | 2012 |